ATAI Life Sciences N.V.ATAI
那斯達克 · USD
4.17
+0.07
(+1.71%)
盤中 08/02 02:30 (UTC+8)
08/02 02:30 (UTC+8)
ATAI Life Sciences N.V.ATAI
4.17
+0.07
(+1.71%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -
- 0.00
- 0.00
- 0.00
- 0.02
- 52.00
- -2.63
- 364.86
- -49.42
- -79.31
- -
- -
- -85.35
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 1,555 | -5 | 40 | 273 | - | 18 | 87 | 172 | 37 | 38 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 1,555 | - | 40 | 273 | - | 18 | 87 | 172 | 37 | 38 |
營業費用 | - | 30,352 | - | 26,003 | 24,085 | 33,579 | 26,920 | 32,035 | 33,251 | 37,603 |
研發費用 | 11,328 | 18,942 | 12,377 | 12,606 | 11,530 | 14,156 | 13,290 | 15,476 | 19,281 | 21,876 |
推銷及管理費用 | 10,597 | 11,318 | 10,274 | 13,397 | 12,555 | 19,423 | 13,630 | 16,559 | 13,970 | 15,727 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | 92 | - | - | - | - | - | - | - | - |
營業利益 | -20,370 | -30,357 | -22,611 | -25,730 | -24,085 | -33,561 | -26,833 | -31,863 | -33,214 | -37,565 |
其他收入及費用 | -5,039 | - | -3,068 | -30,646 | -909 | 15,932 | 71,366 | 863 | 680 | -1,756 |
利息費用 | 900 | 952 | 784 | 701 | 687 | 691 | 685 | 658 | 622 | - |
稅前純益 | -26,309 | -39,184 | -26,463 | -57,077 | -25,681 | -18,320 | 43,848 | -31,658 | -33,156 | -39,321 |
所得稅 | 156 | -193 | -178 | 19 | -4 | 428 | 237 | 186 | 165 | 6,002 |
稅後純益 | -26,431 | -38,958 | -26,286 | -57,312 | -26,713 | -18,292 | 44,246 | -33,043 | -33,135 | -45,011 |
基本每股稅後盈餘(元) | -0.15 | -0.24 | -0.16 | -0.36 | -0.17 | - | 0.28 | -0.21 | -0.21 | -0.28 |
稀釋每股稅後盈餘(元) | -0.15 | -0.24 | -0.16 | -0.36 | -0.17 | -0.11 | 0.28 | -0.21 | -0.21 | -0.29 |
基本平均股數(千股) | 176271.00 | 160711.00 | 160621.00 | 160387.00 | 158891.00 | - | 155792.00 | 155792.00 | 155792.00 | 158703.00 |
稀釋平均股數(千股) | 176271.00 | 160711.00 | 160621.00 | 160387.00 | 158891.00 | - | 177565.00 | 155792.00 | 155792.00 | 158703.00 |
還原基本每股稅後盈餘(元) | -0.15 | -0.24 | -0.16 | -0.36 | -0.17 | - | 0.28 | -0.21 | -0.21 | -0.28 |
還原稀釋每股稅後盈餘(元) | -0.15 | -0.24 | -0.16 | -0.36 | -0.17 | -0.11 | 0.28 | -0.21 | -0.21 | -0.29 |
還原基本平均股數(千股) | 176,271 | 160,711 | 160,621 | 160,387 | 158,891 | - | 155,792 | 155,792 | 155,792 | 158,703 |
還原稀釋平均股數(千股) | 176,271 | 160,711 | 160,621 | 160,387 | 158,891 | - | 177,565 | 155,792 | 155,792 | 158,703 |
EBITDA(千元) | -25,010 | -37,974 | -25,466 | -56,412 | -25,849 | -16,973 | 45,341 | -32,029 | -32,201 | -38,825 |